Please login to the form below

Not currently logged in
Email:
Password:

Cancer therapy deal for Teva and Sinclair

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil, a spray therapy for ongoing supportive cancer care

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil (benzydamine hydrochloride) an oral spray for the treatment of pain in patients undergoing chemotherapy and radiotherapy during cancer treatment.

The licence agreement will see Teva hold exclusive commercialisation rights for episil in Germany, Spain, Poland, Switzerland and the Czech Republic, while Sinclair IS is to retain an option to co-promote the drug in Germany and Spain where it has its own direct sales force.

Financial details of the deal were not disclosed.

Teva said it expects to launch episil in the fourth quarter of 2011.

Chris Spooner, CEO of Sinclair IS, commented that similar agreements were likely for the company in the future. He said: "This is the first in what we expect to be a number of marketing and co-marketing partnerships. episil is a cornerstone of our supportive oncology portfolio and we look forward to working with Teva as we drive sales of this product."

Sinclair IS was formed earlier this year following the merger of Sinclair and IS Pharma.

31st August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics